How much does Entrectinib cost per month in China?

The cost of the drug Entrectinib (Entrectinib) will vary depending on factors such as region, hospital, pharmacy and health insurance. Because drug prices may vary greatly in different countries and regions, and drug pricing is also affected by factors such as market supply and demand, patent status, and drug accessibility, accurate price information cannot be provided.

Entrectinib has been launched in China, but due to its short time on the market, it has not yet been included in the medical insurance catalog. Since it has just been launched, it is difficult to purchase domestically and the price is very high. For specific prices, please consult the hospital pharmacy at that time. There are original drugs and generic drugs abroad. The original drugs abroad are mainly European versions of original drugs. The price is about 45,000 yuan. The price is relatively high and may be unaffordable for ordinary families. Generic drugs are mainly Lao generic drugs, with prices ranging from 4,000 to 8,000yuan, which are much cheaper than original drugs, and the ingredients of original drugs and generic drugs are basically the same.

Enrectinib is a multi-target tyrosine kinase inhibitor (TKI) drug used to treat malignant tumors carrying specific gene mutations. It mainly inhibits the growth and spread of tumors by inhibiting specific abnormal signaling pathways in tumor cells.

Enrectinib interferes with the growth and division of cancer cells by targeting the abnormal signaling pathways caused by these gene mutations, thereby inhibiting the development of tumors. However, it should be noted that entrectinib does not guarantee a complete cure for all tumor patients, and the efficacy will vary depending on individual differences and tumor types. Treatment should be carried out under the guidance of a doctor, and efficacy and side effects should be closely monitored.